Association of type 2 diabetes, hypertension, and hyperlipidemia with immune-related adverse events in patients undergoing immune checkpoint inhibitors therapy - Li, Ruidan; Mu, Xiaoli; Liu, Zheran; Huang, Rendong; Peng, Xingchen (Frontiers in Immunology, 2025)